• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Manal Amoury, Katharina Kolberg, +11 authors Stefan Barth
  • Biology, Medicine
  • Cancer letters
  • 2016 (First Publication: 28 March 2016)
  • Triple-negative breast cancer (TNBC) is associated with poor prognosis and high prevalence among young premenopausal women. Unlike in other breast cancer subtypes, no targeted therapy is currentlyContinue Reading
  • Manal Amoury, Radoslav Mladenov, +13 authors Stefan Barth
  • Biology, Medicine
  • International journal of cancer
  • 2016 (First Publication: 15 August 2016)
  • Chondroitin sulfate proteoglycan 4 (CSPG4) has been identified as a highly promising target antigen for immunotherapy of triple-negative breast cancer (TNBC). TNBC represents a highly aggressiveContinue Reading
  • Mira Woitok, Diana Klose, +9 authors Katharina Kolberg
  • Biology, Medicine
  • Cancer letters
  • 2016 (First Publication: 28 October 2016)
  • Antibody-drug conjugates (ADCs) combine the potency of cytotoxic drugs with the specificity of monoclonal antibodies (mAbs). Most ADCs are currently generated by the nonspecific conjugation ofContinue Reading
  • Mira Woitok, Diana Klose, +8 authors Judith Niesen
  • Medicine
  • OncoTargets and therapy
  • 2017 (First Publication: 6 July 2017)
  • Antibody–drug conjugates (ADCs) can deliver toxins to specific targets such as tumor cells. They have shown promise in preclinical/clinical development but feature stoichiometrically undefinedContinue Reading